In the present study, apigenin significantly inhibited the activation of ERK1/2 and PI3 K/Akt and increased the activation of JNK1/2 and p38 MAPK pathways in cultured uveal melanoma cells. This evidence concerns the gene MAPK3 and uveal melanoma.